Mepower PG 750mcg/75mg Tablet
By Mepower PG
Rx
10 Tablet in a Strip

Composition
Methylcobalamin(750mcg) + Pregabalin(75mg)

Manufacturer - Octavius Pharma Pvt Ltd
403-A, Primate House, Nr. Gormoh Restaurant, Opp. Mother Milk Palace, Judges Bunglows Cross Road, Bodakdev, Ahmedabad – 380015 (Gujarat, India)

Expires on or after
November, 2025

liver
When it comes to using Mepower PG 750mcg/75mg Tablet for patients with liver disease, it is considered safe based on the available information. There is limited data indicating that adjusting the dosage of Mepower PG 750mcg/75mg Tablet may not be necessary for individuals with liver issues. However, it is essential to consult with your doctor before using this medication to ensure it is suitable for your specific situation.

kidney
Mepower PG 750mcg/75mg Tablet requires caution in patients with kidney disease. Adjusting the dose may be necessary. It is essential to consult with your doctor regarding the use of Mepower PG 750mcg/75mg Tablet to ensure safety and effectiveness.

alcohol
Avoid consuming alcohol while taking Mepower PG 750mcg/75mg Tablet as it can increase drowsiness. It is important to be cautious during pregnancy.

driving
It is important to be cautious while driving if you experience decreased alertness, vision issues, drowsiness, or dizziness after taking Mepower PG 750mcg/75mg Tablet. Refrain from driving in such cases.

pregnancy
Mepower PG 750mcg/75mg Tablet may not be safe to use during pregnancy based on limited human studies and animal studies showing potential harm to the baby. Consult your doctor as risks and benefits should be thoroughly evaluated before use.

breastfeeding
Mepower PG 750mcg/75mg Tablet is likely unsafe during breastfeeding, as limited human data indicates potential transfer to breastmilk and harm to the baby. Consult a doctor before use.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹95
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024